Abstract
Certain embodiments are directed to a new human parainfluenza virus (HPIV)/SARS-CoV-2 vaccine or vaccine construct/polynucleotide. In certain aspects the vaccine or vaccine construct is administered via intranasal administration.
| Original language | English (US) |
|---|---|
| Patent number | WO2023133227A2 |
| Filing date | 1/5/23 |
| State | Published - Jul 13 2023 |
Fingerprint
Dive into the research topics of 'A sars-cov-2 human parainfluenza virus type 3-vectored vaccine'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS